CRON vs TRLV
Cronos Group Inc. and Trulieve Cannabis Corp., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CRON | TRLV |
|---|---|---|
| Revenue | $193.4M | $1.2B |
| Net income | $-9.4M | $-122.2M |
| Gross margin | 42.8% | 60.2% |
| Net margin | −2.0% | −10.3% |
| Return on equity | −0.9% | −10.2% |
| Diluted EPS | −$0.02 | −$0.58 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $149,000 | $228.6M |
| Equity | $1.1B | · |
| Net debt / equity | · | −0.10× |
| Current ratio | 19.59× | 4.43× |
| Revenue CAGR 5y | 28.9% | 17.8% |
| Profit CAGR 5y | · | · |
TRLV bills 6.1× the revenue of CRON, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | CRON | TRLV |
|---|---|---|
| FY2025 | $193.4M | $1.2B |
| FY2024 | $161.8M | $1.2B |
| FY2023 | $120.3M | $1.1B |
| FY2022 | $109.3M | $1.2B |
| FY2021 | $79.6M | $931.9M |
| FY2020 | $54.4M | $521.5M |
| FY2019 | $25.6M | $252.8M |
Bottom line
| Fiscal year | CRON | TRLV |
|---|---|---|
| FY2025 | $-9.4M | $-122.2M |
| FY2024 | $41.1M | $-160.6M |
| FY2023 | $-74.0M | $-533.1M |
| FY2022 | $-168.7M | $-252.7M |
| FY2021 | $-396.1M | $17.4M |
| FY2020 | $-73.1M | $63.0M |
| FY2019 | $1.2B | $53.1M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$987,817,000 | TRLV |
| FY2024 | −$1,024,669,000 | TRLV |
| FY2023 | −$1,008,923,000 | TRLV |
| FY2022 | −$1,108,928,000 | TRLV |
| FY2021 | −$852,322,000 | TRLV |
| FY2020 | −$467,180,000 | TRLV |
| FY2019 | −$227,180,000 | TRLV |
TRLV has reported the higher revenue in every one of these 7 fiscal years. The gap has widened since the earliest year compared.
7 of 9 comparable fiscal years — a year missing data on either side is not counted.
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +8.4 pp | CRON |
| FY2024 | +47.6 pp | CRON |
| FY2023 | −38.2 pp | TRLV |
| FY2022 | −173.8 pp | TRLV |
| FY2021 | −617.1 pp | TRLV |
| FY2020 | −173.2 pp | TRLV |
The higher net margin has changed hands between CRON and TRLV over this period.
6 of 9 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CRON's net margin has been more volatile than TRLV's over the 6 comparable fiscal years — 214.4 percentage points of standard deviation against 18.7.
6 of 9 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CRON and TRLV over these 6 fiscal years — CRON led in 2 and TRLV in 4.
6 of 9 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CRON's return on equity has been more volatile than TRLV's over the 7 comparable fiscal years — 46.6 percentage points of standard deviation against 22.3.
7 of 9 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CRON and TRLV over these 7 fiscal years — CRON led in 4 and TRLV in 3.
7 of 9 comparable fiscal years — a year missing data on either side is not counted.